Skip to Primary Navigation

Skip to main content

Canada’s Pharma and Life Sciences Task Force calls for bold action

A photo of Ottawa's Parliament building in silhouette showing sharp spires.
Photo: Al Drago/Getty Images

Kevin Kinsella

2 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

The group urges Canadian government to address affordability, regulatory modernization, and supply-chain resilience.

The Government of Canada has released the final report of the Pharmaceutical and Life Sciences Sector Task Force, a joint initiative led by Health Canada and Innovation, Science and Economic Development Canada.

Co‑chaired by Martin Leblanc of CellCarta Biosciences and Michelle Boudreau, a former senior Health Canada official, the task

, , , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience